Page last updated: 2024-11-01

nifedipine and Chagas Cardiomyopathy

nifedipine has been researched along with Chagas Cardiomyopathy in 1 studies

Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.

Chagas Cardiomyopathy: A disease of the CARDIAC MUSCLE developed subsequent to the initial protozoan infection by TRYPANOSOMA CRUZI. After infection, less than 10% develop acute illness such as MYOCARDITIS (mostly in children). The disease then enters a latent phase without clinical symptoms until about 20 years later. Myocardial symptoms of advanced CHAGAS DISEASE include conduction defects (HEART BLOCK) and CARDIOMEGALY.

Research Excerpts

ExcerptRelevanceReference
"Nifedipine treated mice behaved as controls."1.30GM1 ganglioside induced myocardial restoration and survival of mice with experimental Chagas' disease. ( Bronia, DH; Cossy Isasi, S; Fernandez, AR; Paglini, P, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cossy Isasi, S1
Fernandez, AR1
Paglini, P1
Bronia, DH1

Other Studies

1 other study available for nifedipine and Chagas Cardiomyopathy

ArticleYear
GM1 ganglioside induced myocardial restoration and survival of mice with experimental Chagas' disease.
    Acta tropica, 1999, Oct-15, Volume: 73, Issue:3

    Topics: Animals; Calcium Channel Blockers; Chagas Cardiomyopathy; Chagas Disease; Electrocardiography; G(M1)

1999